التفاصيل البيبلوغرافية
| العنوان: |
Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer. |
| المؤلفون: |
Idris, Sherif, Lindsay, Cameron, Kostiuk, Morris, Andrews, Colin, Côté, David W. J., O'Connell, Daniel A., Harris, Jeffrey, Seikaly, Hadi, Biron, Vincent L. |
| المصدر: |
Journal of Otolaryngology -- Head & Neck Surgery; 10/28/2016, Vol. 45, p1-7, 7p |
| مصطلحات موضوعية: |
OROPHARYNGEAL cancer, CELLULAR signal transduction, IMMUNOHISTOCHEMISTRY, POLYMERASE chain reaction, RESEARCH funding, SQUAMOUS cell carcinoma, EPIGENOMICS, GENETICS |
| مستخلص: |
Background: In recent decades, the incidence of oropharyngeal squamous cell carcinoma (OPSCC) has been rising worldwide as a result of increasing oncogenic human papillomavirus (HPV) infections in the oropharynx. EZH2 is an epigenetic regulatory protein associated with tumor aggressiveness and negative survival outcomes in several human cancers. We aimed to determine the role of EZH2 as a potential therapeutic epigenetic target in HPV-positive and negative OPSCC. Methods: The expression of EZH2 was measured by immunohistochemistry (IHC) and droplet digital PCR (ddPCR) in 2 HPV-positive and 2 HPV-negative cell lines. The cell lines were then cultured and treated with one of 3 EZH2 epigenetic inhibitors (3-deazaneplanocin A, GSK-343 and EPZ005687) or DMSO (control). Following 2, 4 and 7 days of treatment, cells were analyzed and compared by gene expression, cell survival and proliferation assays. Results: EZH2 targeting resulted in greater inhibition of growth and survival in HPV-positive compared to HPV-negative cells lines. The expression profile of genes important in OPSCC also differed according to HPV-positivity for Ki67, CCND1, MET and PTEN/PIK3CA, but remained unchanged for EGFR, CDKN2A and p53. Conclusion: Inhibition of EZH2 has anti-tumorigenic effects on OPSCC cells in culture that is more pronounced in HPV-positive cell lines. EZH2 is a promising epigenetic target for the treatment of OPSCC. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Otolaryngology -- Head & Neck Surgery is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
